The Cole Eye Institute Imaging Summit took place on Thursday, August 10, 2017 prior to the American Society of Retina Specialists (ASRS).

The is a CME symposium focusing on new advances in OCT imaging with hands-on imaging sessions. Attendees will be able to discuss current topics in tomography and imaging with a faculty of distinguished peers. Ocular imaging technology is an area of intense innovation with every year bringing better and more options to the clinic. Outcomes in vision care are best when ophthalmologists, retina specialists, and other eye care health practicioners remain informed of the latest ocular imaging capabilities. Following this course, learners will be able to better select appropriate diagnostic testing and better interpret those tests to improve patient care. Additionally, learners will be made aware of new and exciting modalities of ophthalmic imaging that can be implemented into their clinical practice.

Session Topics

-OCT Angiography: Imaging Challenges and Artifacts
Sumit Sharma, MD

-Novel Approaches for Enhancing OCT-Angiography
Jay S. Duker, MD

-Adaptive Optics: Current Status and Potential Clinical Applications
Joseph Carroll, PhD, FARVO

-When OCT is Not Enough: The Importance of Multimodal Imaging
David Sarraf, MD

-Recent Software and Hardware Advances for Enhanced Visualization of Anatomic and Pathologic Features in Retinal Images
Sina Farsiu, PhD

New and Emerging Trends in Imaging

  • New and Emerging Trends in Imaging

    Drs. Sharma, Duker, Carroll, Sarraf & Farsiu

Release Date: October 10, 2017

Expiration Date: October 10, 2018

Target Audience

The Cole Eye Institute Imaging Summit is for comprehensive ophthalmologists, retina specialists, retina fellows and healthcare providers who are interested in applying the most current, cutting-edge OCT imaging knowledge, including emerging techniques for imaging and treating retinal diseases.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the basic concept of non-confocal AO for improving ophthalmic imaging
  • Discuss novel signal processing software technologies coupled with advanced photonic imaging hardware for enhanced ophthalmic imaging applications
    Criteria for Success

    In order to receive credit, participants should watch the entire video. Statements of credit will be awarded upon successful completion of the quiz and online evaluation/claim credit form. If you have questions about this CME activity, please contact AKH Inc. at jgoldman@akhcme.com

CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

 

Planner Disclosures

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditations

  • Nothing to Disclose

MCME Global Staff and Planners

  • Nothing to Disclose

AKH Staff and Planners

  • Nothing to Disclose

 

Commercial Support
This activity is supported by an educational grant from Alcon, Genentech, Regeneron Pharmaceuticals, Inc. and Santen Pharmaceutical Co., Ltd.

Faculty Disclosures

Joseph Carroll, PhD

  • Consultant: MeiraGtx
  • Research Support: Optovue

Jay S. Duker, MD

  • Board of Directors: Eleven Biotherapeutics; Opthotech
  • Consultant: Allergy Research Group (Ocudyne); Alimera; Allergan; Aura Biosciences; Carl Zeiss Meditec; Ironwood Pharma; Optovue; Topcon Corporation
  • Contracted Research: Carl Zeiss Meditec; Optovue; Topcon Corporation
  • Stock: Hemera Biosciences; Opthotech

Sina Farsiu, PhD

  • Nothing to disclose

David Sarraf, MD

  • Consultant: Amgen; Bayer; Genentech; Optovue
  • Contracted Research: Allerga; Heidelberg; Optovue
  • Speaker Bureau: Bayer; Optovue; Novartis

Sumit Sharma, MD

  • Consultant: Allergan
Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc.

Advancing Knowledge in Healthcare    mcme-logo

X

PRE-QUESTIONS

Please answer the following pre-questions before moving on to the session presentations.

First Name*
Last Name*
Email*

To do OCTA you need all of the following except:

*
Fast OCT hardware
OCT software to develop the “decorrelation signal”
Ability to eliminate motion artifact
A swept source OCT

All of these are disadvantages of OCTA currently EXCEPT:

*
Projection artifacts
Depth encoded
Costly initial investment
Limited field of view
Blocking artifacts

Limitations precluding widespread clinical adoption of AO imaging tools include:

*
The high cost and complexity of AO systems
The relatively small field of view of AO systems
The lack of standardized hardware / FDA-approved devices
All of the above

Adaptive optics technology is needed for what application?

*
Visualizing foveal cones and rod photoreceptors
Visualizing the smallest microvasculature
Correcting OCT-angiography artifacts in the periphery
All of the above